Personal information

No personal information available

Activities

Collapse all

Works (10)

Predictors of the effectiveness of first-line CTLA4-Ig in patients with RA: the FIRST registry

Rheumatology
2024-11-05 | Journal article
DOI: 10.1093/rheumatology/keae598
Contributors: Hiroki Kobayashi; Yusuke Miyazaki; Shingo Nakayamada; Kentaro Hanami; Shunsuke Fukuyo; Satoshi Kubo; Ayako Yamaguchi; Yoshino Inoue; Yasuyuki Todoroki; Hiroko Miyata et al.
Source: check_circle
Crossref

Efficacy, safety and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry

Rheumatology
2024-09-17 | Journal article
DOI: 10.1093/rheumatology/keae495
Contributors: Hidenori Sakai; Yusuke Miyazaki; Shingo Nakayamada; Satoshi Kubo; Kentaro Hanami; Shunsuke Fukuyo; Ayako Yamaguchi; Ippei Miyagawa; Masanobu Ueno; Hiroaki Tanaka et al.
Source: check_circle
Crossref

A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry

Rheumatology and Therapy
2024-06 | Journal article
DOI: 10.1007/s40744-024-00668-z
Contributors: Koshiro Sonomoto; Yoshihisa Fujino; Hiroaki Tanaka; Atsushi Nagayasu; Shingo Nakayamada; Yoshiya Tanaka
Source: check_circle
Crossref

Novel JAK inhibitors under investigation for systemic lupus erythematosus: - where are we now?

Expert Opinion on Investigational Drugs
2023-10-03 | Journal article
DOI: 10.1080/13543784.2023.2264172
Contributors: Shingo Nakayamada; Yoshiya Tanaka
Source: check_circle
Crossref

Immune Phenotype as a Biomarker for Systemic Lupus Erythematosus

Biomolecules
2023-06-08 | Journal article
DOI: 10.3390/biom13060960
Contributors: Shingo Nakayamada; Yoshiya Tanaka
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

JAK inhibitors for rheumatoid arthritis

Expert Opinion on Investigational Drugs
2023-04-03 | Journal article
DOI: 10.1080/13543784.2023.2199919
Contributors: Satoshi Kubo; Shingo Nakayamada; Yoshiya Tanaka
Source: check_circle
Crossref

A case of glucocorticoid-resistant adult Still’s disease complicated by pulmonary hypertension and interstitial lung disease

Modern Rheumatology Case Reports
2023-01-03 | Journal article
DOI: 10.1093/mrcr/rxac081
Contributors: Katsuhide Kusaka; Ippei Miyagawa; Shunpei Kosaka; Satsuki Matsunaga; Shingo Nakayamada; Yoshiya Tanaka
Source: check_circle
Crossref

Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan

Modern Rheumatology
2023-01-03 | Journal article
DOI: 10.1093/mr/roac007
Contributors: Yoshiya Tanaka; Shingo Nakayamada; Kunihiro Yamaoka; Koichiro Ohmura; Shinsuke Yasuda
Source: check_circle
Crossref

Pathological relevance and treatment perspective of JAK targeting in systemic lupus erythematosus

Expert Review of Clinical Immunology
2022-03-04 | Journal article
DOI: 10.1080/1744666X.2022.2040988
Contributors: Shingo Nakayamada; Yoshiya Tanaka
Source: check_circle
Crossref

Clinical relevance of T follicular helper cells in systemic lupus erythematosus

Expert Review of Clinical Immunology
2021-10-03 | Journal article
DOI: 10.1080/1744666X.2021.1976146
Contributors: Shingo Nakayamada; Yoshiya Tanaka
Source: check_circle
Crossref

Peer review (14 reviews for 6 publications/grants)

Review activity for Arthritis research & therapy. (1)
Review activity for Ecotoxicology and environmental safety. (2)
Review activity for Inflammation and regeneration. (1)
Review activity for Modern rheumatology (5)
Review activity for Modern rheumatology case reports. (4)
Review activity for Rheumatology and therapy. (1)
How many people are using ORCID?